NDC 42291-476

Lubiprostone

Lubiprostone

Lubiprostone is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Lubiprostone.

Product ID42291-476_f1763c5a-5f35-fac0-e053-2995a90a038a
NDC42291-476
Product TypeHuman Prescription Drug
Proprietary NameLubiprostone
Generic NameLubiprostone
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2023-01-04
Marketing CategoryANDA /
Application NumberANDA209450
Labeler NameAvKARE
Substance NameLUBIPROSTONE
Active Ingredient Strength24 ug/1
Pharm ClassesChloride Channel Activator [EPC], Chloride Channel Activators [MoA]
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 42291-476-60

60 CAPSULE in 1 BOTTLE (42291-476-60)
Marketing Start Date2023-01-04
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lubiprostone" or generic name "Lubiprostone"

NDCBrand NameGeneric Name
0254-3028LubiprostoneLubiprostone
0254-3029LubiprostoneLubiprostone
0480-3479LubiprostoneLubiprostone
0480-4138LubiprostoneLubiprostone
10370-266LubiprostoneLubiprostone
10370-267LubiprostoneLubiprostone
42291-475LubiprostoneLubiprostone
42291-476LubiprostoneLubiprostone
43598-163LubiprostoneLubiprostone
43598-168LubiprostoneLubiprostone
55700-963LubiprostoneLubiprostone
63304-351Lubiprostonelubiprostone
63304-352Lubiprostonelubiprostone
65162-841LubiprostoneLubiprostone
65162-842LubiprostoneLubiprostone
69339-162LUBIPROSTONELUBIPROSTONE
69339-163LUBIPROSTONELUBIPROSTONE
35356-500Amitizalubiprostone
63629-6398Amitizalubiprostone
64764-080Amitizalubiprostone
64764-240Amitizalubiprostone
68151-5003Amitizalubiprostone
72189-410AmitzaLubiprostone

© 2023 FDA.report
This site is not affiliated with or endorsed by the FDA.